|
HY-13297-1mL
|
MedChemexpress LLC
|
PYZD-4409 [CAS 423148-78-1] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-115510-10mg
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-115510-100mg
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-115510-5mg
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-115510-50mg
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-115510-1mL
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-13002-10mg
|
MedChemexpress LLC
|
Torin 2 [CAS 1223001-51-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13002-100mg
|
MedChemexpress LLC
|
Torin 2 [CAS 1223001-51-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13002-200mg
|
MedChemexpress LLC
|
Torin 2 [CAS 1223001-51-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13002-5mg
|
MedChemexpress LLC
|
Torin 2 [CAS 1223001-51-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13002-50mg
|
MedChemexpress LLC
|
Torin 2 [CAS 1223001-51-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13002-1mL
|
MedChemexpress LLC
|
Torin 2 [CAS 1223001-51-1] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-119402-10mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
|
HY-119402-100mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
|
HY-119402-25mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
|
HY-119402-5mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
|
HY-119402-50mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
|
HY-119402-1mL
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-13271-10mg
|
MedChemexpress LLC
|
Tubastatin A (Hydrochloride) [CAS 1310693-92-5]
|
|
Cancer-programmed cell death
|
|
|
HY-13271-100mg
|
MedChemexpress LLC
|
Tubastatin A (Hydrochloride) [CAS 1310693-92-5]
|
|
Cancer-programmed cell death
|
|
|
HY-13271-200mg
|
MedChemexpress LLC
|
Tubastatin A (Hydrochloride) [CAS 1310693-92-5]
|
|
Cancer-programmed cell death
|
|
|
HY-13271-5mg
|
MedChemexpress LLC
|
Tubastatin A (Hydrochloride) [CAS 1310693-92-5]
|
|
Cancer-programmed cell death
|
|
|
HY-13271-50mg
|
MedChemexpress LLC
|
Tubastatin A (Hydrochloride) [CAS 1310693-92-5]
|
|
Cancer-programmed cell death
|
|
|
HY-13271-1mL
|
MedChemexpress LLC
|
Tubastatin A (Hydrochloride) [CAS 1310693-92-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-13271A-10mg
|
MedChemexpress LLC
|
Tubastatin A [CAS 1252003-15-8]
|
|
Cancer-programmed cell death
|
|
